Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2010
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807672 Compounds that are ERK inhibitors
10/05/2010US7807669 Peroxisome proliferator-activated receptor type gamma (PPAR- gamma) modulators such as (S)-3-{3'-[(benzoylmethylamino)methyl]biphenyl-4-yl}-2-(1-methyl-3-oxo-3-phenylpropenylamino)propionic acid, suited for use in dermatology, immunology, cardiovascular diseases and/or hyperlipemia
10/05/2010US7807659 5-Fluoro-4-oxo-3-[1-(substituted-carbonyl)-2-piperidinecarboxamido]-pentanoic acid derivatives such as [3S/R (2S)]-5-Fluoro-4-oxo-3-[1-(2-phenyl-thiazole-4-carbonyl)-2-piperidinecarboxamido]-pentanoic acid, used for the treatment of bone disorders, inflammatory, autoimmune and degenerative diseases
10/05/2010CA2434900C New use of iloperidone
10/05/2010CA2400479C Platelet adp receptor inhibitors
10/05/2010CA2362930C Nitrosated and nitrosylated proton pump inhibitors, compositions and methods of use
09/2010
09/30/2010WO2010111634A2 Renin inhibitors
09/30/2010WO2010111437A1 Antiviral compounds and uses thereof
09/30/2010WO2010111116A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010WO2010111057A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010111056A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010111050A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010WO2010110400A1 Heterocyclic compound
09/30/2010WO2010110378A1 Pyrazole compound
09/30/2010WO2010110231A1 Substituted 3-hydroxy-4-pyridone derivative
09/30/2010WO2010109442A1 Process for the preparation of desloratadine
09/30/2010WO2010109122A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010WO2010109115A1 Anticancer compounds, preparation thereof, and therapeutic use thereof
09/30/2010WO2010109005A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010WO2010108921A1 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
09/30/2010WO2010108903A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108902A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010WO2010108651A1 Substituted spiro-amide compounds
09/30/2010WO2010108608A1 Substituted piperidines as par-1 antagonists
09/30/2010WO2010078449A3 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
09/30/2010WO2009127949A8 4- [3- (aryloxy) benzylidene] -3-methyl piperidine aryl carboxamide compounds useful as faah inhibitors
09/30/2010US20100249421 Biphenyl compounds useful as muscarinic receptor antagonists
09/30/2010US20100249406 Phenyl-substituted 1,3.5-triazine compound, process for producing the same, and organic electroluminescent device containing the same as component
09/30/2010US20100249405 Organic Compounds
09/30/2010US20100249400 Novel dihydronaphthalene compound and use thereof
09/30/2010US20100249196 Novel Salt Forms Of (2S)-(4E)-N-Methyl-5-[3-(5-Isopropoxypyridin)yl]-4-Penten 2-Amine
09/30/2010US20100249190 Hepatitis C Virus Inhibitors
09/30/2010US20100249187 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
09/30/2010US20100249181 HIV Protease Inhibiting Compounds
09/30/2010US20100249176 Heterocycle amide t-type calcium channel antagonists
09/30/2010US20100249163 Renin inhibitors
09/30/2010US20100249159 Rho-kinase inhibitors
09/30/2010US20100249148 Novel pyrimidine compounds having benzyl (heterocyclic methyl) amine structure and medicament comprising the same
09/30/2010US20100249146 Heteroaryloxy quinazoline derivative
09/30/2010US20100249144 Substituted piperazines as cb1 antagonists
09/30/2010US20100249139 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249132 Imidazole derivatives
09/30/2010US20100249124 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010US20100249117 Factor xa inhibitors
09/30/2010US20100249114 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions
09/30/2010US20100249111 Multi-ring compounds and uses thereof
09/30/2010US20100249098 Oxypiperidine derivatives and methods of use thereof
09/30/2010US20100249096 Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases
09/30/2010US20100249095 Substituted Spiro-amide Compounds
09/30/2010US20100249093 Substituted Heteroarylpiperidine Derivatives As Melanocortin-4 Receptor Modulators
09/30/2010US20100249092 Heteroaryl compounds and uses thereof
09/30/2010US20100249091 Amide Compounds Useful in Therapy
09/30/2010US20100249085 Heteroaryl substituted pyrazole derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
09/30/2010US20100249084 Substituted pyrimidines as adenosine receptor antagonists
09/30/2010US20100249079 Analogues of cilostazol
09/30/2010US20100249077 Pyridylmethyl-Sulfonamide Compounds
09/30/2010US20100249049 Arylalkylamine compound and process for preparing the same
09/30/2010US20100248355 Methods for generating high titer helper-free preparations of released recombinant aav vectors
09/30/2010US20100248264 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
09/30/2010US20100247653 Nanoparticles containing nicotine and/or cotinine, dispersions, and use thereof
09/30/2010US20100247468 Compounds that modulate PPAR gamma-type receptors and cosmetic/pharmaceutical compositions comprising said compounds
09/30/2010US20100247448 Novel lanthanide ligands and complexes, and use thereof as contrast agents
09/30/2010DE102009014484A1 Substituierte Piperidine Substituted piperidines
09/30/2010CA2756769A1 Fluoroquinolone carboxylic acid molecular crystals
09/30/2010CA2756532A1 Substituted spiro-amide compounds
09/30/2010CA2756099A1 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
09/30/2010CA2756086A1 Pyrazole compound
09/30/2010CA2756005A1 Substituted piperidines as par-1 antagonists
09/30/2010CA2755953A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755810A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755806A1 Novel aminopyridine derivatives having aurora a selective inhibitory action
09/30/2010CA2755680A1 P2x3, receptor antagonists for treatment of pain
09/30/2010CA2755023A1 Antiviral compounds and uses thereof
09/30/2010CA2754184A1 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2754176A1 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/30/2010CA2753868A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
09/30/2010CA2660962A1 Novel pharmaceutical composition for treatment of schizophrenia
09/29/2010EP2233483A1 Indole or Benzimidazole derivatives as IkB-kinase modulators and intermediates in their preparation.
09/29/2010EP2233482A1 A crystalline variable hydrate of (s)-6-(4-(2-((3-(9h-carbazol-4-yloxy)-2-hydroxypropyl)amino)-2-methylpropyl)phenoxy)-3-pyridinecarboxamide hemisuccinate salt
09/29/2010EP2233481A1 Method for making mefloquine
09/29/2010EP2233480A1 Chemical compounds
09/29/2010EP2233472A1 Heterocyclic compounds and uses thereof in the treatment of sexual disorders
09/29/2010EP2233470A1 Histamine H3 receptor antagonists
09/29/2010EP2231687A2 Novel derivatives of acyl cyanopyrrolidines
09/29/2010EP2231680A2 Ligands for transition-metal-catalyzed cross-couplings, and methods of use thereof
09/29/2010EP2231679A1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
09/29/2010EP2231666A1 Carboxamide, sulfonamide and amine compounds for metabolic disorders
09/29/2010EP2231659A1 Translocator protein ligands
09/29/2010EP2231649A1 Novel heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase
09/29/2010EP2231646A1 Bis-pyridylpyridones as melanin-concentrating hormone receptor 1 antagonists
09/29/2010EP2231645A2 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231644A2 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressine-dependent diseases
09/29/2010EP2231643A1 Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
09/29/2010EP2231642A1 Pyrimidines as kinase inhibitors
09/29/2010EP2231641A2 Quinoxaline and quinoline derivatives as kinase inhibitors
09/29/2010EP2231640A1 Beta-amino acid derivatives for treatment of diabetes
09/29/2010EP2231639A1 Crystalline forms of n-(tert-butoxycarbonyl)-3-methyl-l-valyl-(4r)-4-((7-chloro-4-methoxy-1-isoquinolinyl)oxy)-n-((1r,2s)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-l-prolinamide
09/29/2010EP2231638A1 Phthalazinone derivatives
09/29/2010EP2231637A1 Pyridazine fungicides
1 ... 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 ... 1080